CA1 and prostate carcinoma: Although the exact mechanism remains unclear, we believe that CA1 mRNA and/or the enzyme CA I play a crucial role in the malignancy of PC3 prostatic cells and might present a novel strategy for the future treatment of prostatic cancer.